Skip to main content

Amylyx Pharmaceuticals, Inc.

AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001658551

In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Amylyx Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
+16 vs. Q4 2024
Shares held
73.9M
+24.1M (+48.4%) vs. Q4 2024
Total value
$261.6M
+$73.3M (+39.0%) vs. Q4 2024
New holders
32
50 more added
Sold out
16
31 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 136 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 72 institutionsQ2 2022: 78 institutionsQ3 2022: 95 institutionsQ4 2022: 133 institutionsQ1 2023: 147 institutionsQ2 2023: 154 institutionsQ3 2023: 170 institutionsQ4 2023: 178 institutionsQ1 2024: 143 institutionsQ2 2024: 119 institutionsQ3 2024: 110 institutionsQ4 2024: 122 institutionsQ1 2025: 136 institutionsQ2 2025: 131 institutionsQ3 2025: 169 institutionsQ4 2025: 180 institutionsQ1 2026: 171 institutionsQ2 2026: 206 institutions
Value heldQ1 2025: $261.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $299.9MQ2 2022: $512.9MQ3 2022: $1.05BQ4 2022: $1.79BQ1 2023: $1.51BQ2 2023: $1.18BQ3 2023: $1.08BQ4 2023: $887.4MQ1 2024: $141.5MQ2 2024: $82.9MQ3 2024: $140.8MQ4 2024: $188.3MQ1 2025: $261.6MQ2 2025: $523.6MQ3 2025: $1.49BQ4 2025: $1.36BQ1 2026: $1.59BQ2 2026: $2.07B
Institutions holding AMLX and their total value by quarter
QuarterHoldersValue
Q2 2026206$2.07B
Q1 2026171$1.59B
Q4 2025180$1.36B
Q3 2025169$1.49B
Q2 2025131$523.6M
Q1 2025136$261.6M
Q4 2024122$188.3M
Q3 2024110$140.8M
Q2 2024119$82.9M
Q1 2024143$141.5M
Q4 2023178$887.4M
Q3 2023170$1.08B
Q2 2023154$1.18B
Q1 2023147$1.51B
Q4 2022133$1.79B
Q3 202295$1.05B
Q2 202278$512.9M
Q1 202272$299.9M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Amylyx Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding AMLX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Ameriprise Financial Inc12,805$45.3K0.00%−37,623−74.6%Reduced
R Squared Ltd12,736$45.1K0.05%+6,366+99.9%Added
Quadrature Capital Ltd12,744$45.0K0.00%+12,744New
Royal Bank of Canada11,850$42.0K0.00%−24−0.2%Reduced
Brevan Howard Capital Management LP11,330$40.1K0.00%+11,330New
Capula Management Ltd10,980$38.9K0.00%+10,980New
EntryPoint Capital, LLC10,587$37.5K0.02%−3,322−23.9%Reduced
Hudson Bay Capital Management LP10,340$36.6K0.00%+10,340New
Valeo Financial Advisors, LLC10,000$35.4K0.00%+10,000New
Tower Research Capital LLC (TRC)6,803$24.1K0.00%−39,184−85.2%Reduced
Russell Investments Group, Ltd.6,700$23.7K0.00%+1,631+32.2%Added
Point72 (DIFC) Ltd5,047$17.9K0.00%+251+5.2%Added
US Bancorp4,000$14.2K0.00%00.0%Unchanged
Simplex Trading, LLC4,162$14.0K0.00%−13,657−76.6%Reduced
Zurcher Kantonalbank (Zurich Cantonalbank)3,152$11.2K0.00%+3,152New
Mirae Asset Global Investments Co., Ltd.2,930$10.7K0.00%+646+28.3%Added
Loring Wolcott & Coolidge Fiduciary Advisors LLP1,803$9.12K0.00%00.0%Unchanged
Advisors Asset Management, Inc.2,573$9.11K0.00%−1,329−34.1%Reduced
Caitong International Asset Management Co., Ltd2,229$7.89K0.01%+2,229New
Steward Partners Investment Advisory, LLC2,000$7.08K0.00%00.0%Unchanged
GF Fund Management Co. Ltd.1,700$6.02K0.00%+261+18.1%Added
BNP Paribas Arbitrage, SA1,363$4.83K0.00%+214+18.6%Added
CWM, LLC890$3.00K0.00%00.0%Unchanged
Dunhill Financial, LLC600$2.12K0.00%00.0%Unchanged
North Capital, Inc.500$1.77K0.00%+500New
Wells Fargo & Company300$1.06K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC285$1.01K0.00%−210−42.4%Reduced
Daiwa Securities Group Inc.266$1.00K0.00%00.0%Unchanged
UMA Financial Services, Inc.274$9700.00%+274New
Coldstream Capital Management Inc238$8430.00%+238New
Harbour Investments, Inc.90$3190.00%00.0%Unchanged
Catherine Avery Investment Management LLC87$3080.00%00.0%Unchanged
Salem Investment Counselors Inc55$1950.00%00.0%Unchanged
The PNC Financial Services Group, Inc.53$1880.00%00.0%Unchanged
EverSource Wealth Advisors, LLC25$890.00%00.0%Unchanged
SBI Securities Co., Ltd.1$40.00%00.0%Unchanged
Ikarian Capital, LLC0$00.00%−201,187−100.0%Sold out
AQR Capital Management LLC0$00.00%−188,386−100.0%Sold out
Mackenzie Financial Corp0$00.00%−111,310−100.0%Sold out
Jump Financial, LLC0$00.00%−104,342−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−80,543−100.0%Sold out
Landscape Capital Management, L.L.C.0$00.00%−49,661−100.0%Sold out
Wedbush Securities Inc0$00.00%−19,914−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−14,809−100.0%Sold out
Rpo LLC0$00.00%−12,136−100.0%Sold out
Alpine Global Management, LLC0$00.00%−12,017−100.0%Sold out
Bank of Nova Scotia0$00.00%−11,884−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−11,788−100.0%Sold out
Vident Advisory, LLC0$00.00%−10,862−100.0%Sold out
Walleye Trading LLC0$00.00%−2,649−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−2,193−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−638−100.0%Sold out
Oliver Lagore Vanvalin Investment Group––––Not filed
Global Retirement Partners, LLC––––Not filed